These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [CONCERNING THE TREATMENT OF XANTHOMATOSIS]. DREWS J Folia Clin Int (Barc); 1963 Sep; 13():416-20. PubMed ID: 14092669 [No Abstract] [Full Text] [Related]
9. [Hyperlipemia: clinico-therapeutic experience with a heparinoid]. De Martino G; D'Aniello L; De Simone E; Belli MG; Buonfantino M Clin Ter; 1978 Sep; 86(6):583-95. PubMed ID: 83925 [No Abstract] [Full Text] [Related]
10. HEPARIN-LIKE SUBSTANCES AND ATHEROSCLEROSIS; A CLINICAL SURVEY AFTER FOUR YEARS OF THERAPEUTIC USE OF A DUODENAL HEPARINOID. COSTA U; AZZENA D; ASTENGO F; GHIGLIOTTI G G Gerontol; 1964 Feb; 12():201-2. PubMed ID: 14163031 [No Abstract] [Full Text] [Related]
11. FIRST RESULTS ON THE TREATMENT OF DISLIPEMIAS OBTAINED WITH THE USE OF A PANCREATIC HEPARIN-LIKE SUBSTANCE. AZZENA D; GHIGLIOTTI G; ASTENGO F; MOLINELLI G G Gerontol; 1964 Feb; 12():169-70. PubMed ID: 14163027 [No Abstract] [Full Text] [Related]
12. On the effect of alimentary lipemia and a natural heparinoid on the fibrinolytic system of man. KONTTINEN Y Scand J Clin Lab Invest; 1962; 14():87-99. PubMed ID: 14458289 [No Abstract] [Full Text] [Related]
13. [ACTION OF DUODENAL HEPARINOID ON GLUCIDE METABOLISM]. BARBEITOARANDA A; PRESS L; GIORDANO J; LOPEZGIL AL; CAMPAGNOLI M Dia Med; 1963 Sep; 35():1491-3. PubMed ID: 14089621 [No Abstract] [Full Text] [Related]
14. [Clinical aspects of the hypocholesterolemic and clearing action of a heparinoid and its relation to atherosclerosis]. ALMAFARA ML; ORLANDO MM Sem Med; 1962 Mar; 120():433-6. PubMed ID: 13860649 [No Abstract] [Full Text] [Related]
16. [Effect exercised by a heparinoid on hyperlipemia induced in the rabbit by a surface-active agent]. BINET L; MARQUIS M; QUIVY D C R Hebd Seances Acad Sci; 1959 Dec; 249():2693-7. PubMed ID: 13800760 [No Abstract] [Full Text] [Related]
17. [Trial of a synthetic heparinoid in the treatment of atherogenic dyslipemia]. Broustet P; Dallocchio M; Crockett R; Bricaud H Gaz Med Fr; 1965 Oct; 72(20):3513-7. PubMed ID: 4159547 [No Abstract] [Full Text] [Related]
18. [Survey of lipid metabolism in 100 patients suspected of atherosclerosis. Therapeutic trial of a new synthetic heparinoid: CB 8061. (Apropos of 30 cases)]. LEBLOIS J; LESAGE R; RIVET E Lille Med; 1962 Mar; 7():256-63. PubMed ID: 14463327 [No Abstract] [Full Text] [Related]
19. [The effect of heparin and heparinoids on aldosterone production]. GLAZ E; SUGAR K Orv Hetil; 1963 Jul; 104():1360-3. PubMed ID: 13948412 [No Abstract] [Full Text] [Related]